- Prostate cancer is the most common cancer in men in the UK.
- Prostate cancer accounts for a quarter of all new cancer cases in men in the UK.
- In 2011 in the UK around 41,700 men were diagnosed with prostate cancer, that's more than 110 every day.
- Over the last 35 years prostate cancer rates in Great Britain have more than tripled, although much of the increase is due to increased detection through widespread use of the PSA test.
- More than a third of prostate cancer cases are diagnosed in men aged over 75 years.
- Most prostate cancer cases are diagnosed at an early stage.
- In Europe, around 417,000 new cases of prostate cancer were estimated to have been diagnosed in 2012. The UK incidence rate is 17th highest in Europe.
- Worldwide, more than 1.11 million men were estimated to have been diagnosed with prostate cancer in 2012, with incidence rates varying across the world.
Prostate cancer statistics
New cases of prostate cancer, 2011, UK
Deaths from prostate cancer, 2012, UK
Survive prostate cancer for 10 or more years, 2010-11, England and Wales
Preventable cases of prostate cancer are not known as it is not clearly linked to any preventable risk factors
- Prostate cancer is the second most common cause of cancer death in UK men, after lung cancer.
- In 2012 in the UK around 10,800 men died from prostate cancer, that's 30 every day.
- Almost three quarters of prostate cancer deaths occur in men aged 75 and over.
- Prostate cancer death rates peaked in the early 1990s and have since fallen by around a fifth.
- In Europe, around 92,300 men were estimated to have died from prostate cancer in 2012. The UK mortality rate is 15th highest in Europe.
- Worldwide, more than 307,000 men were estimated to have died from prostate cancer in 2012, with mortality rates varying across the world.
- In the 1970s, almost 4 in 10 men diagnosed with prostate cancer survived their disease beyond five years, now it’s more than 8 in 10; however, much of this increase can be attributed to the increased use of PSA testing in the UK, which has led to the diagnosis of many prostate cancers which would have gone undetected.
- Forty years ago, more than 2 in 10 men diagnosed with prostate cancer survived their disease for at least ten years, now it is more than 8 in 10; however, much of this increase can be attributed to the increased use of PSA testing in the UK which has led to the diagnosis of many prostate cancers which would have gone undetected.
- Out of 20 common cancers in England and Wales, ten-year survival for prostate cancer ranks 3rd highest.
- Prostate cancer is not clearly linked to any preventable risk factors.
- A man’s risk of developing prostate cancer depends on many factors, including age,genetics, and possibly exposure to risk factors.
- No modifiable factors have been conclusively linked with prostate cancer risk, though many factors have been studied. Use of PSA testing often makes interpretation of evidence difficult.
- Some factors may relate to higher prostate cancer risk, including certain occupational exposures, ionising radiation, and certain medical conditions, but evidence is unclear.
- Some foods and supplements may relate to lower prostate cancer risk, but evidence is unclear.
- GP referral (not ‘two-week wait’) is the most common route to diagnosis of prostate cancer.
- ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ and ‘62-day wait’ are not met by any country for urological cancers.
The latest statistics available for prostate cancer in the UK are; incidence 2011, mortality 2012 and survival 2010-2011.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Stage at diagnosis data is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past.
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2006-2010.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Prostate cancer is part of the group 'Urological cancer' for cancer waiting times data. Codes vary per country but broadly include: penis, prostate, testis, other and unspecified male genital organs, kidney, renal pelvis, ureter, bladder, other and unspecified urinary organs, secondary cancers of kidney, renal pelvis, bladder and other unspecified urinary organs.
You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.